Show Summary Details
Page of

The Neurochemistry of Tourette Syndrome 

The Neurochemistry of Tourette Syndrome
The Neurochemistry of Tourette Syndrome

Harvey S. Singer

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 August 2019

The pathobiology of Tourette syndrome (TS) involves the complex and integrated cortico-striatal-thalamo-cortical (CSTC) circuits. This chapter systematically analyzes the involvement in TS of all the neurotransmitter systems relevant to CSTC circuits. A major role for dopamine continues to be the most consistently observed neurotransmitter change in this condition. Of the various dopaminergic hypotheses proposed, an alteration of the tonic-phasic neurotransmitter release system appears most viable. However, it remains highly likely that TS patients exhibit dysfunction in several neurotransmitter systems, although new evidence is warranted to better understand the dysfunction of non-dopaminergic systems, particularly serotonergic, glutamatergic, and GABAergic ones.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.